Luke C. is an innovative leader with over 22 years of experience in clinical infectious diseases, serving as the Executive Director of Vaccines and Immune Therapy at AstraZeneca since 2025. They have a robust background in clinical development, specializing in early and late-stage trials for novel therapeutics, and have contributed significantly to regulatory filings and approvals in the infectious diseases sector. Luke founded and led the Center for Infection Prevention and Healthcare Epidemiology Research and the Duke Center for Infection Prevention & Healthcare Epidemiology Research, emphasizing the importance of data-driven interventions in healthcare settings. They hold an MBBS (Hons) from the University of Melbourne, an MPH from Johns Hopkins University, and an MBA from the University of North Carolina at Chapel Hill.
This person is not in the org chart
This person is not in any teams
This person is not in any offices